CD9P-1 activators encompass a variety of chemical compounds that indirectly augment its functional activity through distinct biochemical pathways, central to cell-cell interactions and adhesion processes. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Forskolin play pivotal roles in this enhancement. PMA, as a protein kinase C (PKC) activator, directly influences the phosphorylation of substrates involved in CD9P-1 mediated pathways, crucial for immune and endothelial cell interactions. Forskolin, elevating intracellular cAMP levels, indirectly augments CD9P-1's functionality by activating protein kinase A (PKA), which phosphorylates key proteins in pathways where CD9P-1 is essential, such as intercellular communication. Similarly, Ionomycin enhances CD9P-1 activity by increasing intracellular calcium, pivotal for calcium-dependent signaling pathways in which CD9P-1 plays a significant role. Inhibitors like LY294002 and PD98059, targeting PI3K and MEK respectively, alter crucial signaling pathways, indirectly fostering environments conducive to CD9P-1's role in cell migration and adhesion. These chemical interactions indicate a complex network of signaling pathways converging at CD9P-1, emphasizing its integral role in cellular processes.
Continuing the exploration of CD9P-1 activators, compounds like Staurosporine, Sphingosine-1-phosphate, and Thapsigargin further demonstrate the intricate modulation of CD9P-1's activity. Staurosporine, a broad-spectrum kinase inhibitor, potentially enhances CD9P-1's functions by selectively lifting inhibitions exerted by specific kinases on CD9P-1 related processes. The involvement of lipid signaling, as influenced by Sphingosine-1-phosphate, potentiates CD9P-1's role in cellular adhesion, while Thapsigargin, by modulating intracellular calcium levels, further accentuates its function in cell signaling. MEK inhibitors like U0126 and p38 MAPK inhibitor SB203580, by shifting the signaling balance, enhance pathways involving CD9P-1, particularly under stress conditions. Additionally, the influence of tyrosine kinase inhibitor Genistein and Epigallocatechin gallate (EGCG) underscores the diverse molecular interactions that enhance CD9P-1's role in cell communication and adhesion. Collectively, these activators underscore the multifaceted role of CD9P-1 in cellular processes, particularly highlighting its importance in cell adhesion and communication through the modulation of various signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA, a potent PKC activator, enhances CD9P-1 activation. PKC plays a crucial role in CD9P-1 mediated cell-cell interactions, particularly in immune and endothelial cells, by phosphorylating substrates that influence these interactions. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which indirectly augments CD9P-1 functionality. Elevated cAMP activates PKA, which can phosphorylate key proteins involved in pathways where CD9P-1 is critical, such as intercellular communication and adhesion. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin, a calcium ionophore, enhances CD9P-1 activity by increasing intracellular calcium levels, which is essential for the activation of calcium-dependent signaling pathways involved in CD9P-1 mediated cell adhesion and signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly influences CD9P-1 activity by modulating the PI3K/AKT pathway, crucial for several cellular processes in which CD9P-1 is involved, such as cell migration and adhesion. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, an MEK inhibitor, alters the MAPK/ERK pathway. By inhibiting this pathway, the equilibrium shifts, potentially enhancing pathways where CD9P-1 is active, particularly in cellular communication and adhesion processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, can lead to selective activation of CD9P-1 pathways by reducing the inhibition exerted by specific kinases on processes related to CD9P-1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate engages in lipid signaling, which can potentiate CD9P-1 mediated functions in cellular adhesion and communication by activating or modulating sphingolipid pathways that intersect with CD9P-1 functions. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin, by increasing intracellular calcium levels, enhances CD9P-1 activity. This elevation in calcium activates pathways crucial for cell adhesion and signaling, where CD9P-1 plays a significant role. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, a p38 MAPK inhibitor, alters signaling pathways, potentially enhancing those in which CD9P-1 is active, particularly in stress response and cellular communication. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can enhance CD9P-1 activity by reducing competition from tyrosine kinase signaling, thus favoring pathways where CD9P-1 is involved in cell communication and adhesion. | ||||||